Oranda Therapeutics
Oranda Therapeutics is dedicated to pioneering innovations in medicine commercialisation to improve the lives of those living with rare diseases. Their mission is to be the partner of choice for BioPharma SMEs in bringing innovative medicines to European patients with life-threatening or chronically debilitating conditions. The company emphasizes commercial excellence, patient access, and collaboration with partners to ensure effective treatment delivery.
Industries
Nr. of Employees
small (1-50)
Oranda Therapeutics
Services
End-to-end partnership arrangements to commercialize innovative medicines for rare diseases, including strategy co-creation and project governance.
Identification, negotiation and acquisition of rights to pharmaceutical assets for regional commercialization and distribution.
Operational distribution and market entry support across EU and adjacent territories via direct operations and managed strategic partners.
Development and execution of market access plans, pricing strategies and reimbursement engagement across international markets.
Planning and operational execution of medicine launches, including establishment of medico-marketing operating clusters.
Advisory services on medical affairs and product development strategies specific to rare disease medicines.
End-to-end partnership arrangements to commercialize innovative medicines for rare diseases, including strategy co-creation and project governance.
Identification, negotiation and acquisition of rights to pharmaceutical assets for regional commercialization and distribution.
Operational distribution and market entry support across EU and adjacent territories via direct operations and managed strategic partners.
Development and execution of market access plans, pricing strategies and reimbursement engagement across international markets.
Planning and operational execution of medicine launches, including establishment of medico-marketing operating clusters.
Advisory services on medical affairs and product development strategies specific to rare disease medicines.
Expertise Areas
- Orphan and rare disease commercialization
- Market access and pricing & reimbursement
- In-licensing and asset acquisition
- Commercial launch planning and execution
Key Technologies
- Commercial launch planning methodologies
- Market access and reimbursement frameworks
- Pricing strategy development
- In-licensing deal structuring